Showing results (91-100 of 148) with videos related to
Sort By:
Pageof 15
Small Methods|February 12, 2019
Monitoring Neutropenia for Cancer Patients at the Point of CareHakan Inan, James L Kingsley, Mehmet O Ozen, et al.JTO Clinical and Research Reports|February 8, 2024
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic TumorsKathryn E Beckermann, Christine M Bestvina, Badi El Osta, et al.Clinical Lung Cancer|December 8, 2023
Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non-Small-Cell Lung CancerCaressa Hui, Cesar Marquez, Brianna Lau, et al.Clinical Lung Cancer|December 10, 2021
Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on OsimertinibMaya N White, Andrew J Piper-Vallillo, Rebecca M Gardner, et al.Nature Machine Intelligence|November 29, 2021
Radiological tumor classification across imaging modality and histologyJia Wu, Chao Li, Michael Gensheimer, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2018
Progress in the Management of Early-Stage Non-Small Cell Lung Cancer in 2017Jessica S Donington, Young Tae Kim, Betty Tong, et al.Oncology|June 24, 2019
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid TumorsDavid Hong, Drew Rasco, Michael Veeder, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2Lucio Crinò, Myung-Ju Ahn, Filippo De Marinis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) GuidelineHumera Khurshid, Nofisat Ismaila, Jessica Bian, et al.NPJ Precision Oncology|June 26, 2026
Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biologyJennifer A Marks, Rohan Maniar, Kavitha J Ramchandran, et al.Pageof 15